Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of “Hold” from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have received an average recommendation of “Hold” from the eleven analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $57.00.

RHHBY has been the topic of a number of research analyst reports. Morgan Stanley reissued an “underweight” rating on shares of Roche in a research report on Wednesday, February 4th. TD Cowen reissued a “hold” rating on shares of Roche in a research report on Tuesday, February 10th. Wolfe Research reissued an “outperform” rating on shares of Roche in a research report on Thursday, February 26th. The Goldman Sachs Group raised Roche from a “sell” rating to a “hold” rating in a research report on Thursday, January 15th. Finally, Citigroup initiated coverage on Roche in a research report on Tuesday, January 27th. They issued a “buy” rating on the stock.

Roche Trading Up 0.1%

Shares of OTCMKTS RHHBY opened at $51.33 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. Roche has a 52-week low of $35.07 and a 52-week high of $60.85. The business’s 50 day moving average is $53.34 and its two-hundred day moving average is $50.59.

Hedge Funds Weigh In On Roche

Institutional investors have recently modified their holdings of the business. Curio Wealth LLC acquired a new position in shares of Roche in the third quarter worth $25,000. Oakworth Capital Inc. acquired a new position in shares of Roche in the third quarter worth $57,000. Salomon & Ludwin LLC grew its stake in shares of Roche by 256.6% in the third quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock worth $129,000 after acquiring an additional 2,053 shares in the last quarter. Atlas Capital Advisors Inc. purchased a new position in shares of Roche in the 4th quarter valued at about $192,000. Finally, Douglass Winthrop Advisors LLC purchased a new position in shares of Roche in the 3rd quarter valued at about $201,000.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.